Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SARS-CoV-2 B.1.1.7 escape from mRNA vaccine-elicited neutralizing antibodies
Ravindra K. Gupta, Dami A. Collier, Anna De Marco, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

The effect of spike mutations on SARS-CoV-2 neutralization
Chloe Rees-Spear, Luke Muir, Sarah Griffith, et al.
Cell Reports (2021) Vol. 34, Iss. 12, pp. 108890-108890
Open Access | Times Cited: 235
Covid-19: The E484K mutation and the risks it poses
Jacqui Wise
BMJ (2021), pp. n359-n359
Closed Access | Times Cited: 223
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Jalen Singh, Pranav Pandit, Andrew G. McArthur, et al.
Virology Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 141
SARS-CoV-2 Variant of Concern 202012/01 Has about Twofold Replicative Advantage and Acquires Concerning Mutations
Frederic Grabowski, Grzegorz Preibisch, Stanisław Giziński, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 392-392
Open Access | Times Cited: 105
Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape
Jonathan C. Brown, Daniel H. Goldhill, Jie Zhou, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 96
The emergence of new strains of SARS-CoV-2. What does it mean for COVID-19 vaccines?
Md Kamal Hossain, Majid Hassanzadeganroudsari, Vasso Apostolopoulos
Expert Review of Vaccines (2021) Vol. 20, Iss. 6, pp. 635-638
Open Access | Times Cited: 87
Protective roles and protective mechanisms of neutralizing antibodies against SARS-CoV-2 infection and their potential clinical implications
Endeshaw Chekol Abebe, Tadesse Asmamaw Dejenie
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 35
Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern.
Donal Skelly, Adam Harding, Javier Gilbert‐Jaramillo, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 52
Age-related heterogeneity in immune responses to SARS-CoV-2 vaccine BNT162b2
Dami A. Collier, Isabella A. T. M. Ferreira, Prasanti Kotagiri, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 51
SARS-CoV-2 Variant of Concern 202012/01 has about twofold replicative advantage and acquires concerning mutations
Frederic Grabowski, Grzegorz Preibisch, Stanisław Giziński, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 40
Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies
Peter R. McIlroy, Le Thanh Mai Pham, Thomas Sheffield, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 1, pp. e1012903-e1012903
Open Access
Pandemic moves and countermoves: vaccines and viral variants
Rogier W. Sanders, Menno D. de Jong
The Lancet (2021) Vol. 397, Iss. 10282, pp. 1326-1327
Open Access | Times Cited: 36
SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges
Judith Wellens, Jean‐Frédéric Colombel, Jack Satsangi, et al.
Journal of Crohn s and Colitis (2021) Vol. 15, Iss. 8, pp. 1376-1386
Open Access | Times Cited: 29
SARS-CoV-2 mutations in Brazil: from genomics to putative clinical conditions
Luís Fernando Saraiva Macedo Timmers, Júlia Vasconcellos Peixoto, Rodrigo G. Ducati, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Two doses of SARS-CoV-2 vaccination induce more robust immune responses to emerging SARS-CoV-2 variants of concern than does natural infection.
Donal Skelly, Adam Harding, Javier Gilbert‐Jaramillo, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 24
Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection
Morgane Rolland, Peter B. Gilbert
PLoS Pathogens (2021) Vol. 17, Iss. 3, pp. e1009406-e1009406
Open Access | Times Cited: 21
Negative-Binomial and quasi-poisson regressions between COVID-19, mobility and environment in São Paulo, Brazil
Sérgio Ibarra-Espinosa, Edmílson Dias de Freitas, Karl Ropkins, et al.
Environmental Research (2021) Vol. 204, pp. 112369-112369
Open Access | Times Cited: 17
The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization
Arghavan Zebardast, Parastoo Hosseini, Ali Hasanzadeh, et al.
Molecular Biology Reports (2021) Vol. 49, Iss. 1, pp. 647-656
Open Access | Times Cited: 13
The Evolution of Severe Acute Respiratory Syndrome Coronavirus-2 during Pandemic and Adaptation to the Host
Snawar Hussain, Sahibzada Tasleem Rasool, Pottathil Shinu
Journal of Molecular Evolution (2021) Vol. 89, Iss. 6, pp. 341-356
Open Access | Times Cited: 10
Coding-Complete Genome Sequences and Mutation Profiles of Nine SARS-CoV-2 Strains Detected from COVID-19 Patients in Bangladesh
Nihad Adnan, Mohib Ullah Khondoker, M. Shaminur Rahman, et al.
Microbiology Resource Announcements (2021) Vol. 10, Iss. 10
Open Access | Times Cited: 9
A new SARS-CoV-2 lineage that shares mutations with known Variants of Concern is rejected by automated sequence repository quality control
Bryan Thornlow, Angie S. Hinrichs, Miten Jain, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 6
What Are the Clinical Implications of the SARS-CoV-2 Variants
Adriana M. Rauseo, Jane A. O’Halloran
JACC Basic to Translational Science (2021) Vol. 6, Iss. 3, pp. 305-308
Open Access | Times Cited: 5
Prediction and evolution of the molecular fitness of SARS-CoV-2 variants: Introducing SpikePro
Fabrizio Pucci, Marianne Rooman
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 5
Natural and vaccine-induced antibody and cellular responses against emerging SARS-CoV-2 variants of concern
Donal Skelly, Adam Harding, Javier Gilbert‐Jaramillo, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 4
Negative-Binomial and Quasi-Poisson regressions between COVID-19, mobility and environment in São Paulo, Brazil
Sérgio Ibarra-Espinosa, Edmílson Dias de Freitas, Karl Ropkins, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top